|
1
|
Nakamura M and Sadoshima J: Mechanisms of
physiological and pathological cardiac hypertrophy. Nat Rev
Cardiol. 15:387–407. 2018. View Article : Google Scholar
|
|
2
|
Shimizu I and Minamino T: Physiological
and pathological cardiac hypertrophy. J Mol Cell Cardiol.
97:245–262. 2016. View Article : Google Scholar
|
|
3
|
Zhu L, Li C, Liu Q, Xu W and Zhou X:
Molecular biomarkers in cardiac hypertrophy. J Cell Mol Med.
23:1671–1677. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gallo S, Vitacolonna A, Bonzano A,
Comoglio P and Crepaldi T: ERK: A key player in the pathophysiology
of cardiac hypertrophy. Int J Mol Sci. 20:21642019. View Article : Google Scholar
|
|
5
|
Wang L, Wang J, Li G and Xiao J:
Non-coding RNAs in physiological cardiac hypertrophy. Adv Exp Med
Biol. 1229:149–161. 2020. View Article : Google Scholar
|
|
6
|
Tham YK, Bernardo BC, Ooi JY, Weeks KL and
McMullen JR: Pathophysiology of cardiac hypertrophy and heart
failure: Signaling pathways and novel therapeutic targets. Arch
Toxicol. 89:1401–1438. 2015. View Article : Google Scholar
|
|
7
|
Bisping E, Wakula P, Poteser M and Heinzel
FR: Targeting cardiac hypertrophy: Toward a causal heart failure
therapy. J Cardiovasc Pharmacol. 64:293–305. 2014. View Article : Google Scholar
|
|
8
|
Hou J and Kang YJ: Regression of
pathological cardiac hypertrophy: Signaling pathways and
therapeutic targets. Pharmacol Ther. 135:337–354. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Persengiev SP and Green MR: The role of
ATF/CREB family members in cell growth, survival and apoptosis.
Apoptosis. 8:225–228. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zabala V, Boylan JM, Thevenot P, Frank A,
Senthoor D, Iyengar V, Kim H, Cohen A, Gruppuso PA and Sanders JA:
Transcriptional changes during hepatic ischemia-reperfusion in the
rat. PLoS One. 14:e02270382019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shi Z, Zhang K, Chen T, Zhang Y, Du X,
Zhao Y, Shao S, Zheng L, Han T and Hong W: Transcriptional factor
ATF3 promotes liver fibrosis via activating hepatic stellate cells.
Cell Death Dis. 11:10662020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Qian L, Zhao Y, Guo L, Li S and Wu X:
Activating transcription factor 3 (ATF3) protects against
lipopolysaccharide-induced acute lung injury via inhibiting the
expression of TL1A. J Cell Physiol. 232:3727–3734. 2017. View Article : Google Scholar
|
|
13
|
Chen SC, Liu YC, Shyu KG and Wang DL:
Acute hypoxia to endothelial cells induces activating transcription
factor 3 (ATF3) expression that is mediated via nitric oxide.
Atherosclerosis. 201:281–288. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bueno M, Brands J, Voltz L, Fiedler K,
Mays B, St Croix C, Sembrat J, Mallampalli RK, Rojas M and Mora AL:
ATF3 represses PINK1 gene transcription in lung epithelial cells to
control mitochondrial homeostasis. Aging Cell. 17:e127202018.
View Article : Google Scholar
|
|
15
|
Zhao W, Sun M, Li S, Chen Z and Geng D:
Transcription factor ATF3 mediates the radioresistance of breast
cancer. J Cell Mol Med. 22:4664–4675. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ku HC and Cheng CF: Master regulator
activating transcription factor 3 (ATF3) in metabolic homeostasis
and cancer. Front Endocrinol (Lausanne). 11:5562020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kumar M, Majumder D, Mal S, Chakraborty S,
Gupta P, Jana K, Gupta UD, Ghosh Z, Kundu M and Basu J: Activating
transcription factor 3 modulates the macrophage immune response to
Mycobacterium tuberculosis infection via reciprocal regulation of
inflammatory genes and lipid body formation. Cell Microbiol.
22:e131422020. View Article : Google Scholar
|
|
18
|
Zhou H, Li N, Yuan Y, Jin YG, Guo H, Deng
W and Tang QZ: Activating transcription factor 3 in cardiovascular
diseases: A potential therapeutic target. Basic Res Cardiol.
113:372018. View Article : Google Scholar
|
|
19
|
Qin W, Yang H, Liu G, Bai R, Bian Y, Yang
Z and Xiao C: Activating transcription factor 3 is a potential
target and a new biomarker for the prognosis of atherosclerosis.
Hum Cell. 34:49–59. 2021. View Article : Google Scholar
|
|
20
|
Li YL, Hao WJ, Chen BY, Chen J and Li GQ:
Cardiac fibroblast-specific activating transcription factor 3
promotes myocardial repair after myocardial infarction. Chin Med J
(Engl). 131:2302–2309. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhou H, Shen DF, Bian ZY, Zong J, Deng W,
Zhang Y, Guo YY, Li H and Tang QZ: Activating transcription factor
3 deficiency promotes cardiac hypertrophy, dysfunction, and
fibrosis induced by pressure overload. PLoS One. 6:e267442011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhou Y, Xie Y, Li T, Zhang P, Chen T, Fan
Z and Tan X: P21-activated kinase 1 mediates angiotensin II-induced
differentiation of human atrial fibroblasts via the JNK/c-Jun
pathway. Mol Med Rep. 23:2072021. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gwathmey TM, Pendergrass KD, Reid SD, Rose
JC, Diz DI and Chappell MC:
Angiotensin-(1–7)-angiotensin-converting enzyme 2 attenuates
reactive oxygen species formation to angiotensin II within the cell
nucleus. Hypertension. 55:166–171. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang LL, Li DY, Zhang YB, Zhu MY, Chen D
and Xu TD: Salvianolic acid A inhibits angiotensin II-induced
proliferation of human umbilical vein endothelial cells by
attenuating the production of ROS. Acta Pharmacol Sin. 33:41–48.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C (T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhai CG, Xu YY, Tie YY, Zhang Y, Chen WQ,
Ji XP, Mao Y, Qiao L, Cheng J, Xu QB and Zhang C: DKK3
overexpression attenuates cardiac hypertrophy and fibrosis in an
angiotensin-perfused animal model by regulating the ADAM17/ACE2 and
GSK-3β/β-catenin pathways. J Mol Cell Cardiol. 114:243–252. 2018.
View Article : Google Scholar
|
|
27
|
Sheng R, Gu ZL, Xie ML, Zhou WX and Guo
CY: EGCG inhibits proliferation of cardiac fibroblasts in rats with
cardiac hypertrophy. Planta Med. 75:113–120. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ji Y, Qiu M, Shen Y, Gao L, Wang Y, Sun W,
Li X, Lu Y and Kong X: MicroRNA-327 regulates cardiac hypertrophy
and fibrosis induced by pressure overload. Int J Mol Med.
41:1909–1916. 2018.PubMed/NCBI
|
|
29
|
Nyunt T, Britton M, Wanichthanarak K,
Budamagunta M, Voss JC, Wilson DW, Rutledge JC and Aung HH:
Mitochondrial oxidative stress-induced transcript variants of ATF3
mediate lipotoxic brain microvascular injury. Free Radic Biol Med.
143:25–46. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li Y, Li Z, Zhang C, Li P, Wu Y, Wang C,
Bond Lau W, Ma XL and Du J: Cardiac fibroblast-specific activating
transcription factor 3 protects against heart failure by
suppressing MAP2K3-p38 signaling. Circulation. 135:2041–2057. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pan J, Xu Z, Guo G, Xu C, Song Z, Li K,
Zhong K and Wang D: Circ_nuclear factor I X (circNfix) attenuates
pressure overload-induced cardiac hypertrophy via regulating
miR-145-5p/ATF3 axis. Bioengineered. 12:5373–5385. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen C, Ge C, Liu Z, Li L, Zhao F, Tian H,
Chen T, Li H, Yao M and Li J: ATF3 inhibits the tumorigenesis and
progression of hepatocellular carcinoma cells via upregulation of
CYR61 expression. J Exp Clin Cancer Res. 37:2632018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chaqour B: Regulating the regulators of
angiogenesis by CCN1 and taking it up a Notch. J Cell Commun
Signal. 10:259–261. 2016. View Article : Google Scholar
|
|
34
|
Bonda TA, Kamiński KA, Dziemidowicz M,
Litvinovich S, Kożuch M, Hirnle T, Dmitruk I, Chyczewski L and
Winnicka MM: Atrial expression of the CCN1 and CCN2 proteins in
chronic heart failure. Folia Histochem Cytobiol. 50:99–103. 2012.
View Article : Google Scholar
|
|
35
|
Wang J, Fu D, Senouthai S, Jiang Y, Hu R
and You Y: Identification of the transcriptional networks and the
involvement in Angiotensin II-induced injury after
CRISPR/Cas9-mediated knockdown of Cyr61 in HEK293T cells. Mediators
Inflamm. 2019:86972572019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hilfiker A, Hilfiker-Kleiner D, Fuchs M,
Kaminski K, Lichtenberg A, Rothkötter HJ, Schieffer B and Drexler
H: Expression of CYR61, an angiogenic immediate early gene, in
arteriosclerosis and its regulation by angiotensin II. Circulation.
106:254–260. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
You JJ, Yang CM, Chen MS and Yang CH:
Regulation of Cyr61/CCN1 expression by hypoxia through cooperation
of c-Jun/AP-1 and HIF-1α in retinal vascular endothelial cells. Exp
Eye Res. 91:825–836. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Meyer K, Hodwin B, Ramanujam D, Engelhardt
S and Sarikas A: Essential role for premature senescence of
myofibroblasts in myocardial fibrosis. J Am Coll Cardiol.
67:2018–2028. 2016. View Article : Google Scholar
|
|
39
|
Li L, Fan D, Wang C, Wang JY, Cui XB, Wu
D, Zhou Y and Wu LL: Angiotensin II increases periostin expression
via Ras/p38 MAPK/CREB and ERK1/2/TGF-β1 pathways in cardiac
fibroblasts. Cardiovasc Res. 91:80–89. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wu X, Liu Y, An J, Li J, Lv W, Geng S and
Zhang Y: Piperlongumine inhibits angiotensin II-induced
extracellular matrix expression in cardiac fibroblasts. J Cell
Biochem. 119:10358–10364. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Leask A and Abraham DJ: All in the CCN
family: Essential matricellular signaling modulators emerge from
the bunker. J Cell Sci. 119:4803–4810. 2006. View Article : Google Scholar
|
|
42
|
Borkham-Kamphorst E, Schaffrath C, Van de
Leur E, Haas U, Tihaa L, Meurer SK, Nevzorova YA, Liedtke C and
Weiskirchen R: The anti-fibrotic effects of CCN1/CYR61 in primary
portal myofibroblasts are mediated through induction of reactive
oxygen species resulting in cellular senescence, apoptosis and
attenuated TGF-β signaling. Biochim Biophys Acta. 1843:902–914.
2014. View Article : Google Scholar
|
